<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03536013</url>
  </required_header>
  <id_info>
    <org_study_id>DSP17-002</org_study_id>
    <nct_id>NCT03536013</nct_id>
  </id_info>
  <brief_title>Efficacy of a Full-Thickness Placental Allograft in Lumbar Microdiscectomy</brief_title>
  <official_title>A Clinical Investigation Evaluating Efficacy of a Full-Thickness Placental Allograft in Lumbar Microdiscectomy Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>StimLabs</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>StimLabs</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the efficacy of full thickness placental allograft use in Microdiscectomy
      application. To evaluate post-microdiscectomy reherniation rate in patients treated with
      full-thickness placental allografts.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective is to evaluate the efficacy of full thickness placental allograft use
      in improving back and leg pain, when applied to patients undergoing lumbar microdiscectomy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 3, 2018</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Blind study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measuring efficacy of full-thickness placental allograft in reducing back and leg pain post-microdiscectomy.</measure>
    <time_frame>24 months</time_frame>
    <description>Oswestry Disability Index (ODI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measuring efficacy of full-thickness placental allograft in reducing back and leg pain post-microdiscectomy.</measure>
    <time_frame>24 months</time_frame>
    <description>12-Item Short Form Survey (SF12)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of post-microdiscectomy reherniation rate.</measure>
    <time_frame>24 month</time_frame>
    <description>Reherniation rates will be compared between the experimental and control groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">182</enrollment>
  <condition>Surgical Wound</condition>
  <condition>Herniation</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>91 patients will undergo a typical lumbar microdiscectomy with the addition of a full-thickness placental allograft after the microdiscectomy has been performed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>91 patients will undergo a typical lumbar microdiscectomy without the addition of a full-thickness placental allograft.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Other: Full-thickness placental allograft</intervention_name>
    <description>A full-thickness placental allograft will be applied to the annulus of the index lumbar level prior to site closure.</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ambulatory with radiating low back and leg pain for greater than 6 months prior to
             surgery with clinical diagnosis of lumbar protruding disc.

          -  Consent and compliance with all aspects of the study protocol, methods, providing data
             during follow-up contact.

        Exclusion Criteria:

          -  Severe hypertension systolic blood pressure (greater than or equal to 200 mm -Hg or
             diastolic blood pressure greater than or equal to 182 mm Hg)

          -  BMI greater than 45 kg/m2

          -  Subject has had major surgery at the index level

          -  Is an active smoker or stopped smoking in the last 6 months

          -  Any pain that could interfere with the assessment of index level pain (e.g. pain in
             any other part of the spine)

          -  Active rheumatoid arthritis

          -  Active, local or systemic malignancy such as lung cancer or leukemia

          -  History of vascular disease or sickle cell anemia

          -  Use of the following medications:

        No significant anticoagulant therapy (e.g. Heparin or Lovenox) during the study (treatment
        such as Aspirin and Plavix are allowed)

          -  No systemic treatments that may interfere with safety or efficacy assessments during
             the study

          -  No immunosuppressants

          -  No use of corticosteroids

               -  Subject is pregnant or plans to become pregnant within 24 months of treatment

               -  Subject does not provide full consent

               -  Personal injury, workman's compensation or other legally-related treatment
                  patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Morrison, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Polaris Spine and Neurosurgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Operations Supervisor, B.S.</last_name>
    <phone>4044870398</phone>
    <email>brock@stimlabs.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Director of Marketing, B.S.</last_name>
    <phone>4049366099</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Polaris Spine and Neurosurgery</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30328</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlie Ivie</last_name>
      <phone>404-256-2633</phone>
      <phone_ext>163</phone_ext>
      <email>civie@polarisspine.com</email>
    </contact>
    <contact_backup>
      <last_name>Lydia Jones</last_name>
      <phone>4042562633</phone>
      <email>lwjones95@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Thomas Morrison, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northside Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Gamache</last_name>
      <phone>404-256-2633</phone>
      <phone_ext>110</phone_ext>
      <email>SGamache@polarisspine.com</email>
    </contact>
    <contact_backup>
      <last_name>Carlie Ivie</last_name>
      <phone>404-256-2633</phone>
      <phone_ext>163</phone_ext>
      <email>civie@polarisspine.com</email>
    </contact_backup>
    <investigator>
      <last_name>Thomas Morrison, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 30, 2018</study_first_submitted>
  <study_first_submitted_qc>May 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2018</study_first_posted>
  <last_update_submitted>May 23, 2018</last_update_submitted>
  <last_update_submitted_qc>May 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The sponsor will not have access to personally identifying participant information.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

